NexGel, Inc. (NASDAQ:NXGL – Get Free Report) CEO Adam Levy sold 4,000 shares of NexGel stock in a transaction that occurred on Thursday, November 6th. The shares were sold at an average price of $2.52, for a total transaction of $10,080.00. Following the transaction, the chief executive officer owned 367,692 shares of the company’s stock, valued at $926,583.84. The trade was a 1.08% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.
NexGel Stock Up 3.8%
Shares of NexGel stock traded up $0.09 during midday trading on Friday, hitting $2.48. The company had a trading volume of 57,997 shares, compared to its average volume of 67,456. NexGel, Inc. has a 52-week low of $2.10 and a 52-week high of $5.10. The company has a debt-to-equity ratio of 0.16, a quick ratio of 0.98 and a current ratio of 1.74. The stock has a market capitalization of $20.19 million, a P/E ratio of -6.20 and a beta of 0.57. The company has a 50 day moving average of $2.47 and a 200 day moving average of $2.46.
NexGel (NASDAQ:NXGL – Get Free Report) last announced its quarterly earnings data on Tuesday, August 12th. The company reported ($0.09) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.07) by ($0.02). NexGel had a negative net margin of 25.02% and a negative return on equity of 49.37%. The company had revenue of $2.88 million for the quarter, compared to analysts’ expectations of $3.08 million.
Institutional Investors Weigh In On NexGel
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of NexGel in a report on Wednesday, October 8th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, NexGel currently has an average rating of “Sell”.
Read Our Latest Analysis on NXGL
About NexGel
NEXGEL, Inc manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc and changed its name to NEXGEL, Inc in November 2019.
Recommended Stories
- Five stocks we like better than NexGel
- Dividend Payout Ratio Calculator
- OpenAI’s Restructuring Sets up What Could Be the Biggest IPO Ever
- Ride Out The Recession With These Dividend Kings
- 2 Rare Earth Stocks the U.S. Government Doesn’t Want to Fail
- Using the MarketBeat Stock Split Calculator
- CrowdStrike Partners With CoreWeave But Investors Sell the News
Receive News & Ratings for NexGel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NexGel and related companies with MarketBeat.com's FREE daily email newsletter.
